VERTEX PHARMACEUTICALS INC / MA 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 1, 2007
Insider Transaction Report
Form 4
ALAM JOHN J
SVP, Drug Eval. & Appr.
Transactions
- Sale
Common Stock
2007-01-31$35.46/sh−1,000$35,460→ 135,960 total - Exercise/Conversion
Stock Options
2007-01-31−1,000→ 1,966 totalExercise: $18.47Exp: 2007-09-25→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2007-01-31$18.47/sh+1,000$18,470→ 136,460 total - Exercise/Conversion
Stock Options
2007-01-31−500→ 9,400 totalExercise: $9.07From: 2004-03-11Exp: 2013-12-10→ Common Stock (500 underlying) - Exercise/Conversion
Common Stock
2007-01-31$9.07/sh+500$4,535→ 136,960 total - Sale
Common Stock
2007-01-31$35.46/sh−500$17,730→ 135,460 total
Holdings
- 6,265(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1.
- [F2]Fully exercisable.
- [F3]Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003.